Literature DB >> 8629424

Primary squamous cell carcinoma of the liver: a case report.

T Shinagawa1, M Tadokoro, M Takagi, R Yasuda, Y Adachi, H Komoriyama, S Yamaguchi.   

Abstract

BACKGROUND: Bile cytology from percutaneous transhepatic cholangio-drainage (PTCD) is a useful procedure in case of obstructive jaundice. CASE: Repeated cytology via PTCD from a cystically dilated duct in a 56-year-old female with a long clinical history permitted a diagnosis of squamous cell carcinoma (SCC). The smears showed excessive benign-appearing squamous cells with or without a nucleus and a few keratinized- and nonkeratinized-type SCC cells. No adenocarcinoma-derived cells were identified. No focus of SCC was detected clinically. The resected hepatic specimen disclosed a keratinized-type SCC simultaneous with benign metaplastic squamous epithelium.
CONCLUSION: This case of cytology of primary SCC of the liver seems to be the first reported. Even when showing a great number of benign-appearing squamous cells, the possibility of malignancy should not be ruled out. Repeating the cytology from PTCD is effective for a diagnosis.

Entities:  

Mesh:

Year:  1996        PMID: 8629424     DOI: 10.1159/000333765

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  Primary squamous cell carcinoma of the liver: a successful surgically treated case.

Authors:  Hsiang-Lin Lee; Yu-Yin Liu; Chun-Nan Yeh; Kun-Chun Chiang; Tse-Ching Chen; Yi-Yin Jan
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Primary squamous cell carcinoma of the liver associated with hepatolithiasis: a case report.

Authors:  Ke-Lei Zhu; Ding-Yao Li; Cun-Bing Jiang
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 3.  Primary Squamous Cell Carcinoma of Liver: Case Series and Review of Literatures.

Authors:  Xu-Feng Zhang; Zhao-Qing Du; Xue-Min Liu; Yi Lv
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.